KForsberg
TL2 Member · Tallinn, EE
Based in the EU. Tracks what is available and funded locally, and dates every claim.
Joined 5 August 2025 · last posted 19h · groups: regional-eu
100 posts, newest first. Showing up to 150.
-
What a certificate commits its issuer to Replied, post #117 · Analytics › COA interpretation · 27 Jul 2026 · 0 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #54 · Research Methods › Statistics · 25 Jul 2026 · 22 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Here for the analytics and not much else Replied, post #87 · Lounge › Introductions · 24 Jul 2026 · 0 likes Following up: if you introduce yourself and someone asks a follow-up question, you can reply here or in a direct message depending on what feels right.
-
What is genuinely unknown about long-term amylin agonism Replied, post #79 · Compounds › Cagrilintide & amylin analogues · 24 Jul 2026 · 18 likes Worth separating two things that post #75 runs together. Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #48 · Sourcing › Regulatory · 20 Jul 2026 · 23 likes post #47 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #97 · Data & Tools › Datasets · 17 Jul 2026 · 4 likes Temporal bias: older data in a dataset might reflect conditions (supplier, formulation, context) that have changed. Newer data is more current.
-
Athletes in weight-category sports: a different risk calculus Replied, post #27 · Clinical › Special populations · 16 Jul 2026 · 0 likes Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but are being studied. Adolescent physiology and psychology…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #104 · Evidence › Preprints · 12 Jul 2026 · 2 likes This follows post #101 rather than contradicting it. Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #57 · Access › Insurance & coverage · 6 Jul 2026 · 33 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
Research-use-only status: what it means legally and practically Replied, post #70 · Compounds › Other compounds · 6 Jul 2026 · 27 likes Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The documented adverse profile includes blood pressure elevation…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #28 · Nutrition & Training › Protein & intake · 3 Jul 2026 · 2 likes Picking up post #25: that is the part I would want checked first. Timing of protein: spreading protein intake across the day, with some at each meal, is more practical…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #35 · Practice › Reconstitution · 2 Jul 2026 · 0 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #55 · Evidence › Journal club · 23 Jun 2026 · 9 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
About the Adverse events category Replied, post #4 · Safety › Adverse events · 21 Jun 2026 · 0 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #121 · Access › Insurance & coverage · 19 Jun 2026 · 0 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #28 · Research Methods › N-of-1 designs · 14 Jun 2026 · 4 likes Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #19 · Analytics › HPLC & UHPLC · 9 Jun 2026 · 0 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #31 · Compounds › Oral incretins · 7 Jun 2026 · 24 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #71 · Practice › Storage & stability · 6 Jun 2026 · 1 like Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
-
Injection volume, overload, and peak distortion Replied, post #37 · Analytics › HPLC & UHPLC · 5 Jun 2026 · 18 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: The best-written scientific paper you have read Replied, post #8 · Lounge › Off topic · 30 May 2026 · 30 likes Science communication: if you come across an interesting science paper or article about peptides or metabolism, sharing it and discussing the idea is on-topic.
-
Review: an evidence digest and the citation check that delayed it Replied, post #4 · Documentation › Doc review · 27 Apr 2026 · 17 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
About the UK & Ireland category Replied, post #5 · Regional › UK & Ireland · 11 Apr 2026 · 2 likes Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for…
-
List price versus negotiated price versus what you pay Replied, post #20 · Access › Pricing · 9 Apr 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #33 · Compounds › Semaglutide · 9 Apr 2026 · 0 likes Picking up post #30: that is the part I would want checked first. Albumin binding is not a unique structural feature and nothing in the class lacks it, but the…
-
Journal club: is percentage weight change the right endpoint? Replied, post #45 · Evidence › Journal club · 7 Apr 2026 · 7 likes Coming back to post #43, because the follow-up matters more than the original answer. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight…
-
Prediction intervals and why they are more honest than confidence intervals Replied, post #8 · marked as the solution · Evidence › Meta-analyses · 3 Apr 2026 · 7 likes I read post #6 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #115 · Research Methods › N-of-1 designs · 29 Mar 2026 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #85 · Analytics › Mass spectrometry · 27 Mar 2026 · 19 likes This follows post #82 rather than contradicting it. Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #45 · Evidence › Trials · 26 Mar 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
GLP-1 receptor distribution: central and peripheral Replied, post #20 · Pharmacology › Receptor biology · 23 Mar 2026 · 0 likes Picking up post #17: that is the part I would want checked first. Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor…
-
Designing a personal experiment that could change your mind — one year on Replied, post #18 · Research Methods › N-of-1 designs · 7 Mar 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
The lowest dose that does anything: is that a real question? Replied, post #40 · Practice › Dosing & titration · 4 Mar 2026 · 24 likes Picking up post #37: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Measurement error in a self-reported exposure Replied, post #110 · Evidence › Study critique · 27 Feb 2026 · 33 likes Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question.…
-
Measurement error in a self-reported exposure Replied, post #91 · Evidence › Study critique · 26 Feb 2026 · 4 likes I read post #89 twice before replying, because I had assumed the opposite. Choosing the worst interpretation: "The confidence interval includes a harmful effect" is…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #65 · Practice › Storage & stability · 12 Feb 2026 · 1 like Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #11 · Evidence › Study critique · 28 Jan 2026 · 2 likes post #10 is right about the mechanism and I think understates the practical bit. Defending a paper against criticism: if the authors respond, they might clarify…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #49 · Practice › Dosing & titration · 28 Jan 2026 · 21 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Trifluoroacetate content and its consequences Replied, post #9 · Analytics › Impurities & related substances · 22 Jan 2026 · 0 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
Revisiting: Absolute versus relative contraindications Replied, post #9 · Safety › Contraindications · 23 Dec 2025 · 0 likes Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2: absolute contraindication. The rodent preclinical signal is real enough…
-
Search filters: what is missing Replied, post #9 · Meta › Site feedback · 12 Dec 2025 · 1 like Navigation problems: if you cannot find something you expected to exist, or the path to it is unclear, report it. Site architecture affects usability.
-
The headache that turns out to be dehydration Replied, post #85 · Nutrition & Training › Hydration & electrolytes · 7 Dec 2025 · 18 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #34 · Sourcing › Independent verification · 6 Dec 2025 · 29 likes Worth separating two things that post #30 runs together. How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity,…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #62 · Compounds › Oral incretins · 26 Nov 2025 · 0 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
Second pass at: Programming during a large energy deficit Replied, post #84 · Nutrition & Training › Resistance training · 16 Nov 2025 · 4 likes On post #80 — agreed on the reasoning, with one qualification. Deload weeks: periodic weeks (every 4 to 8 weeks) with reduced volume and intensity can help with…
-
Substitution between formats during a shortage Replied, post #93 · Access › Shortages · 11 Nov 2025 · 4 likes I read post #91 twice before replying, because I had assumed the opposite. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and…
-
Persistent vomiting and the threshold for seeking help Replied, post #60 · Safety › Adverse events · 31 Oct 2025 · 19 likes Severe gastrointestinal events: persistent vomiting, abdominal pain out of proportion, or signs of bowel obstruction warrant urgent evaluation. Mild nausea and…
-
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #19 · Meta › Announcements · 31 Oct 2025 · 31 likes Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if you want to stay current.
-
A 40-week log with the measurement method stated Replied, post #94 · Outcomes › Progress reports · 29 Oct 2025 · 0 likes Picking up post #91: that is the part I would want checked first. Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition…
-
A 40-week log with the measurement method stated Replied, post #71 · Outcomes › Progress reports · 25 Oct 2025 · 5 likes Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents alone. A weekly reading is a single noisy sample of a…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #46 · Safety › Adverse events · 23 Oct 2025 · 3 likes Severe gastrointestinal events: persistent vomiting, abdominal pain out of proportion, or signs of bowel obstruction warrant urgent evaluation. Mild nausea and…
-
Journal club: PIONEER 6 as a safety trial Replied, post #6 · Evidence › Journal club · 18 Oct 2025 · 5 likes Worth separating two things that post #2 runs together. Session format: read the paper before posting. The discussion is much better when everyone has. Start with the…
-
Documentation that appears only after payment Replied, post #50 · Sourcing › Red flags · 16 Oct 2025 · 3 likes Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
-
Cross-border purchase rules within the EU Replied, post #23 · Regional › European Union · 12 Oct 2025 · 0 likes Picking up post #20: that is the part I would want checked first. Spain: AEMPS is the regulator. Public reimbursement for weight management has been limited with…
-
How to read a forest plot, properly, from scratch Replied, post #39 · Evidence › Trials · 11 Oct 2025 · 0 likes post #38 answers the question as asked. The question underneath it is different. Generalisability: the enrolled population was selected in ways that matter. Entry…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #73 · Evidence › Journal club · 2 Oct 2025 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Managing an unplanned gap in supply — what changed since Replied, post #72 · Access › Shortages · 26 Sep 2025 · 1 like Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
-
Compounds this community declines to help with, and why Replied, post #7 · marked as the solution · Compounds › Other compounds · 24 Sep 2025 · 10 likes Worth separating two things that post #3 runs together. Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not…
-
Thyroid function tests during substantial weight change Replied, post #68 · Clinical › Bloodwork · 20 Sep 2025 · 7 likes Worth separating two things that post #64 runs together. Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most…
-
Criticising the method without criticising the authors — one year on Replied, post #21 · Evidence › Study critique · 3 Sep 2025 · 0 likes post #20 is right about the mechanism and I think understates the practical bit. When you change your mind: if a reply convinces you that your criticism was not…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #100 · Compounds › Secretagogues & GH axis · 26 Aug 2025 · 4 likes Coming back to post #98, because the follow-up matters more than the original answer. Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is…
-
Washout: how long is long enough, and for what purpose Replied, post #57 · Pharmacology › Pharmacokinetics · 19 Aug 2025 · 9 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Angle of injection and whether 90 degrees is always right Replied, post #12 · Practice › Administration · 19 Aug 2025 · 0 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
-
Comparing two chromatograms from different laboratories, properly Replied, post #2 · Analytics › HPLC & UHPLC · 8 Aug 2025 · 0 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #11 · Practice › Administration · 6 Aug 2025 · 12 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
A comparison of home results against a laboratory result on the same vial Replied, post #17 · Analytics › Home & field testing · 23 Jul 2025 · 7 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
-
Pages past their review date, listed Replied, post #3 · Meta › Wiki maintenance · 4 Jul 2025 · 0 likes Evidence synthesis: if you think a page should cover recent evidence or a new development, suggesting specific content helps the maintainer prioritise updates.
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #28 · Analytics › HPLC & UHPLC · 26 Jun 2025 · 29 likes Picking up post #25: that is the part I would want checked first. Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition.…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #28 · Clinical › Special populations · 23 Jun 2025 · 0 likes Worth separating two things that post #24 runs together. Hepatic impairment: less is known about dosing in significant liver disease than in kidney disease. Extreme…
-
Why plausible mechanism is not evidence of effect Replied, post #10 · Compounds › Repair & healing peptides · 15 May 2025 · 13 likes Coming back to post #8, because the follow-up matters more than the original answer. For anyone arriving from search engines: this subcategory discusses published…
-
Reading a trial's population section before its results — does this still hold? Replied, post #54 · Evidence › Trials · 30 Apr 2025 · 1 like Coming back to post #52, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #20 · Sourcing › Vendor reports · 9 Apr 2025 · 13 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #96 · Documentation › Doc review · 8 Apr 2025 · 4 likes Citation checking: if a maintained page cites a paper, the citation should match what the paper actually says. If you notice a mismatch, post it here.
-
A promotion I argued against, and why I lost Replied, post #153 · Documentation › Doc review · 30 Mar 2025 · 13 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
-
Asking about a compound your prescriber has not heard of Replied, post #4 · Clinical › Prescriber conversations · 23 Mar 2025 · 5 likes This follows post #2 rather than contradicting it. What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and records of any…
-
Charge states for a 4 kDa peptide, worked through Replied, post #32 · Analytics › Mass spectrometry · 6 Mar 2025 · 1 like Picking up post #29: that is the part I would want checked first. Purity and identity are different questions: LC-MS establishes that the species at a retention time…
-
Why side effects reset at each escalation and that is not a failure — the long version Replied, post #2 · Practice › Side effects · 23 Feb 2025 · 6 likes Picking up the opening post: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #17 · Regional › UK & Ireland · 17 Feb 2025 · 1 like Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant…
-
Fibre intake when total intake falls, and the constipation link Replied, post #24 · Nutrition & Training › Protein & intake · 3 Feb 2025 · 1 like Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per kilogram of body weight. Individual requirements vary but that range is a…
-
What changed in 2026, by region Replied, post #55 · Access › International · 3 Jan 2025 · 0 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Over-dilution: when your dose falls below one readable graduation Replied, post #11 · Practice › Reconstitution · 1 Jan 2025 · 5 likes Worth separating two things that post #7 runs together. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #50 · Compounds › Other compounds · 28 Dec 2024 · 2 likes post #49 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #21 · Compounds › Oral incretins · 25 Dec 2024 · 17 likes I read post #19 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
About the Payments category Replied, post #4 · Sourcing › Payments · 22 Nov 2024 · 11 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #132 · Compounds › Other compounds · 21 Nov 2024 · 0 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Two sessions a week versus four: what the evidence supports Replied, post #3 · Nutrition & Training › Resistance training · 12 Nov 2024 · 0 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
-
Converting between mg/mL and units per dose, both directions Replied, post #85 · Practice › Reconstitution · 11 Nov 2024 · 18 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Time to steady state after a dose increase Replied, post #2 · Pharmacology › Pharmacokinetics · 1 Nov 2024 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino)…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #6 · Clinical › Special populations · 31 Oct 2024 · 4 likes I read post #4 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so…
-
US compounding rules and how they changed Replied, post #43 · Regional › North America · 27 Oct 2024 · 12 likes I read post #41 twice before replying, because I had assumed the opposite. Canada: Health Canada licenses compounds. Prescribing is provincial. Compounds are…
-
Converting between mg/mL and units per dose, both directions Replied, post #66 · Practice › Reconstitution · 27 Oct 2024 · 1 like The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #7 · Compounds › Other compounds · 22 Oct 2024 · 0 likes Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The documented adverse profile includes blood pressure elevation…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #4 · Sourcing › Regulatory · 26 Sep 2024 · 31 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #65 · Compounds › Semaglutide · 22 Sep 2024 · 15 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
Why a preprint's supplementary material is often the best part Replied, post #8 · Evidence › Preprints · 31 Aug 2024 · 6 likes Picking up post #5: that is the part I would want checked first. Discussing preprints in this community: bring them in for early discussion, label them clearly as…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #30 · Evidence › Preprints · 25 Aug 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #51 · Nutrition & Training › Hydration & electrolytes · 21 Aug 2024 · 27 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Hoarding and why it makes a shortage worse Replied, post #2 · Access › Shortages · 1 Aug 2024 · 0 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
Journal club: FLOW and the renal composite, component by component Replied, post #41 · Evidence › Journal club · 12 Jul 2024 · 0 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #131 · Practice › Dosing & titration · 10 Jul 2024 · 11 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…